Jeff Renwick

Jeff Renwick has over 20 years of experience in the pharmaceutical and biotech industries. Jeff has held various positions including CEO, Chief Scientific Officer, and Director. Jeff is currently the CEO of Canntab Therapeutics.

Jeff started their career in 1999 as Business Development for Indukern Chemie AG. In 2004, they became the Director for Alliance Grain Traders and held that position for 12 years. During their time as Director, Jeff was instrumental in the company's founding period. In 2016, they left Alliance Grain Traders to join Standard Biochem Inc. as CEO. Jeff was with Standard Biochem Inc. for less than a year before moving on to Canntab Therapeutics Inc. in May of 2017. Jeff has been with Canntab Therapeutics as CEO for almost 3 years.

Under Jeff's leadership, Canntab Therapeutics has become a drug discovery and formulation development company. They have made significant advancements in technology and have managed several research projects successfully. Jeff is dedicated to their work and is always looking for ways to improve the company and its products.

Some direct reports include Tommy Larocque - Procurement, Larry Latowsky - Special Advisor, and Richard Goldstein - CFO.